The sold call produces a 9.83% annualized yield in addition to the dividend. The post Bristol Myers Stock: This Covered Call Could Enhance Your Return Beyond A 4% Dividend Yield appeared first on Investor's Business Daily.
Bristol Myers Squibb is a New Jersey-based biopharmaceutical company that discovers, develops and commercializes medicines for patients with serious diseases.